IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
IGC Pharma, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.24−0.00 (-1.63%)
Close on Oct 19, 2026
- Market cap
- $24.28M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of IGC Pharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 20, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 5, 2026 | Jan 6, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2025 | Jan 2, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 10, 2025 | Aug 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Mar 31, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2024 | Sep 27, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 23, 2024 | Aug 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2024 | Aug 2, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 23, 2024 | Jul 8, 2024 | SEC EDGAR |
| Annual report | 10-K | Mar 31, 2024 | Jun 24, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2024 | Apr 5, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 22, 2024 | Mar 28, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2024 | Mar 22, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2024 | Mar 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2023 | Feb 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 9, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2023 | Oct 27, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2023 | Aug 21, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 10, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 18, 2023 | Jul 26, 2023 | SEC EDGAR |
| Annual report | 10-K | Mar 31, 2023 | Jul 7, 2023 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2023 | Jul 7, 2023 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2023 | Jul 7, 2023 | SEC EDGAR |